NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.
about
Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).Development of neuropeptide drugs that cross the blood-brain barrier.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review.Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity-diabetes.Characterization and Identification of Cryptic Biopeptides in Carya illinoinensis (Wangenh K. Koch) Storage Proteins.Gut hormone polyagonists for the treatment of type 2 diabetes.Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.
P2860
Q33224640-30905575-8C60-4B53-A568-382CFECD17ADQ33569277-D1044E40-6925-456F-BCEE-23F27A173B27Q35189265-5D7D21BA-23C9-4467-A294-DCD577DC852CQ35962745-2A36706B-3B47-44B3-A878-4427FB506703Q38363899-2E355F58-20DC-4BE5-BBA0-24ED0BB3455BQ47161130-D2BF7EAB-0B0A-4B04-A56B-14434019CD07Q49218095-E289BCD3-6F5D-4FE4-82E3-D0013E4843EBQ49266925-641D1E13-1000-4735-AC86-B231BB4B563A
P2860
NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@en
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@nl
type
label
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@en
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@nl
prefLabel
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@en
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@nl
P2093
P1433
P1476
NH2-terminally modified gastri ...... ed antihyperglycemic activity.
@en
P2093
P304
P356
10.2337/DIABETES.48.4.758
P407
P577
1999-04-01T00:00:00Z